No Data
TIANJIN DEV: Annual Report 2024
Lisheng Pharmaceutical's Profit Slips in Q1
Express News | Tianjin Development - Qtrly Total Operating Income of Tianjin Lisheng Pharmaceutical RMB369.8 Mln
TIANJIN DEV: Unaudited Financial Results for the three months ended 31 March 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV (00882) announced its annual results, with a profit attributable to shareholders of 0.548 billion HKD, a year-on-year decrease of 13.78%. It plans to declare a final dividend of 8.82 HK cents per share.
TIANJIN DEV (00882) announced its annual results for the year ending December 31, 2024, with group revenue of 33.59...
Express News | Tianjin Development Holdings FY Net Income HKD 548.1 Million